Digital sovereignty has gained new urgency amid rising geopolitical tensions, with some European IT leaders reconsidering their reliance on global cloud providers.
To be considered a true prescription digital therapeutic, the software must be authorized by the Food and Drug Administration (FDA), which gives users greater confidence in its usage and outcomes.